Literature DB >> 19492946

Serologic surveillance for West Nile virus and other flaviviruses in febrile patients, encephalitic patients, and asymptomatic blood donors in northern Mexico.

María de Lourdes Garza Rodríguez1, Diana R Rodríguez Rodriguez, Bradley J Blitvich, Miguel A Reyes López, Ildefonso Fernández-Salas, Javier Ramos Jimenez, José A Farfán-Ale, Rogelio Cazares Tamez, César Martinez Longoria, Maria I Tavitas Aguilar, Ana Maria Rivas-Estilla.   

Abstract

A clinical and serological investigation was performed to determine the presence of West Nile virus (WNV) among febrile and encephalitic patients in northern Mexico. In addition, asymptomatic blood donors were serologically assayed for WNV to determine the seroprevalence of WNV in the general population. The study cohort consisted of 1432 individuals (588 febrile patients, 44 encephalitic patients, and 800 asymptomatic blood donors). All subjects were negative for WNV IgM. Sixty subjects were reactive for dengue virus (DENV) IgM (16 blood donors and 44 febrile patients). A subset (n = 425) of individuals was also screened by ELISA for flavivirus IgG. The prevalence of flavivirus IgG in febrile patients, encephalitic patients, and blood donors ranged from 40% to 59%. A subset (n = 147) of sera reactive for flavivirus IgG was further tested by plaque reduction neutralization test. Six individuals with no history of travel during the preceding 12 months were seropositive for WNV. Another 65 individuals were seropositive for DENV1 and 24 were seropositive for DENV2. The high prevalence of dengue antibodies in northern Mexico appears to limit the incidence of WNV infection in this region. Article Summary Line: Antibodies to WNV, DENV-1, and DENV-2 were identified in humans in northern Mexico.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19492946      PMCID: PMC2883485          DOI: 10.1089/vbz.2008.0203

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  35 in total

1.  Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile Virus infection.

Authors:  G Tardei; S Ruta; V Chitu; C Rossi; T F Tsai; C Cernescu
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century.

Authors:  Duane J Gubler
Journal:  Trends Microbiol       Date:  2002-02       Impact factor: 17.079

3.  The outbreak of West Nile virus infection in the New York City area in 1999.

Authors:  D Nash; F Mostashari; A Fine; J Miller; D O'Leary; K Murray; A Huang; A Rosenberg; A Greenberg; M Sherman; S Wong; M Layton
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

4.  Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States.

Authors:  Denise A Martin; Brad J Biggerstaff; Becky Allen; Alison J Johnson; Robert S Lanciotti; John T Roehrig
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

5.  Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections.

Authors:  D A Martin; D A Muth; T Brown; A J Johnson; N Karabatsos; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey.

Authors:  F Mostashari; M L Bunning; P T Kitsutani; D A Singer; D Nash; M J Cooper; N Katz; K A Liljebjelke; B J Biggerstaff; A D Fine; M C Layton; S M Mullin; A J Johnson; D A Martin; E B Hayes; G L Campbell
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

7.  Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.

Authors:  R S Lanciotti; J T Roehrig; V Deubel; J Smith; M Parker; K Steele; B Crise; K E Volpe; M B Crabtree; J H Scherret; R A Hall; J S MacKenzie; C B Cropp; B Panigrahy; E Ostlund; B Schmitt; M Malkinson; C Banet; J Weissman; N Komar; H M Savage; W Stone; T McNamara; D J Gubler
Journal:  Science       Date:  1999-12-17       Impact factor: 47.728

Review 8.  Transmission dynamics and changing epidemiology of West Nile virus.

Authors:  Bradley J Blitvich
Journal:  Anim Health Res Rev       Date:  2008-03-19       Impact factor: 2.615

9.  Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis.

Authors:  Robert B Tesh; Amelia P A Travassos da Rosa; Hilda Guzman; Tais P Araujo; Shu-Yuan Xiao
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

Review 10.  Global spread and persistence of dengue.

Authors:  Jennifer L Kyle; Eva Harris
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

View more
  13 in total

1.  [Mosquito-transmitted infections].

Authors:  T Jelinek
Journal:  Internist (Berl)       Date:  2018-01       Impact factor: 0.743

2.  Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.

Authors:  Matthew R Vogt; Kimberly A Dowd; Michael Engle; Robert B Tesh; Syd Johnson; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

3.  Dynamic transmission of West Nile virus across the United States-Mexican border.

Authors:  Brian R Mann; Allison R McMullen; Hilda Guzman; Robert B Tesh; Alan D T Barrett
Journal:  Virology       Date:  2012-11-07       Impact factor: 3.616

4.  Enhanced West Nile virus surveillance in a dengue-endemic area--Puerto Rico, 2007.

Authors:  Jomil M Torres-Aponte; Richard R Luce; Elizabeth Hunsperger; Jorge L Muñoz-Jordan; Manuela Beltrán; Edgardo Vergne; D Fermín Argüello; Enid J García; Wellington Sun; Kay M Tomashek
Journal:  Am J Trop Med Hyg       Date:  2013-03-11       Impact factor: 2.345

5.  Orthobunyaviruses, a common cause of infection of livestock in the Yucatan peninsula of Mexico.

Authors:  Bradley J Blitvich; Rungrat Saiyasombat; Amelia Travassos da Rosa; Robert B Tesh; Charles H Calisher; Julian E Garcia-Rejon; José A Farfán-Ale; Rubén E Loroño; Arturo Bates; Maria A Loroño-Pino
Journal:  Am J Trop Med Hyg       Date:  2012-10-08       Impact factor: 2.345

6.  Surveillance for Flaviviruses Near the Mexico-U.S. Border: Co-circulation of Dengue Virus Serotypes 1, 2, and 3 and West Nile Virus in Tamaulipas, Northern Mexico, 2014-2016.

Authors:  S Viridiana Laredo-Tiscareño; Javier A Garza-Hernandez; Ma Isabel Salazar; Erick J De Luna-Santillana; Chandra S Tangudu; Rosa C Cetina-Trejo; Gloria L Doria-Cobos; Santos Daniel Carmona-Aguirre; Julian E Garcia-Rejon; Carlos Machain-Williams; Bradley J Blitvich; Mario Alberto Rodríguez Pérez
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

7.  Orthobunyavirus antibodies in humans, Yucatan Peninsula, Mexico.

Authors:  Bradley J Blitvich; Rungrat Saiyasombat; Lourdes G Talavera-Aguilar; Julian E Garcia-Rejon; Jose A Farfan-Ale; Carlos Machain-Williams; Maria A Loroño-Pino
Journal:  Emerg Infect Dis       Date:  2012-10       Impact factor: 6.883

8.  The distribution of potential West Nile virus vectors, Culex pipiens pipiens and Culex pipiens quinquefasciatus (Diptera: Culicidae), in Mexico City.

Authors:  Alvaro Diaz-Badillo; Bethany G Bolling; Gerardo Perez-Ramirez; Chester G Moore; Jorge P Martinez-Munoz; America A Padilla-Viveros; Minerva Camacho-Nuez; Alfonso Diaz-Perez; Barry J Beaty; Maria de Lourdes Munoz
Journal:  Parasit Vectors       Date:  2011-05-09       Impact factor: 3.876

9.  Identification of class I HLA T cell control epitopes for West Nile virus.

Authors:  Saghar Kaabinejadian; Paolo A Piazza; Curtis P McMurtrey; Stephen R Vernon; Steven J Cate; Wilfried Bardet; Fredda B Schafer; Kenneth W Jackson; Diana M Campbell; Rico Buchli; Charles R Rinaldo; William H Hildebrand
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

10.  Fatal human case of West Nile disease, Mexico, 2009.

Authors:  Clara Rios-Ibarra; Bradley J Blitvich; Jose Farfan-Ale; Javier Ramos-Jimenez; Sissy Muro-Escobedo; Hector R Martínez-Rodriguez; Rocío OrtizLópez; Ernesto Torres-López; Ana María Rivas-Estilla
Journal:  Emerg Infect Dis       Date:  2010-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.